Neil Lerner
Neil Lerner has made 2 open-market purchases worth $21k since Sep 25, 2026, in 1 company. The latest: $18k of CMPX, filed Oct 2, 2026, scored 26 out of 100.
Chief Accounting Officer, Compass Therapeutics, Inc.
Follow Neil Lerner, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 2 Form 4 (opens sec.gov) |
CMPXCompass Therapeutics, Inc. · Chief Accounting OfficerChief Accounting Officer · Near 52-week low · Penny stock: hard to trade | +5% stake | 26 | $18k 20,000 at $0.92 |
— | — |
| Sep 25 Form 4 (opens sec.gov) |
CMPXCompass Therapeutics, Inc. · Chief Accounting OfficerChief Accounting Officer · Near 52-week low · Penny stock: hard to trade | +1% stake | 22 | $3k 2,500 at $1.14 |
— | — |
Questions
What stock has Neil Lerner bought?
CMPX (Compass Therapeutics, Inc.), all on the open market and reported on SEC Form 4.
When did Neil Lerner last buy?
Oct 2, 2026: 20,000 shares of CMPX at $0.92, $18k in all (Form 4 (opens sec.gov)).
Has Neil Lerner filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Neil Lerner a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 2, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer